Ironwood Pharmaceuticals (IRWD) Short term Debt (2016 - 2026)

Ironwood Pharmaceuticals (IRWD) has 9 years of Short term Debt data on file, last reported at $199.9 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt changed N/A year-over-year to $199.9 million; the trailing twelve-month figure through Mar 2026 stood at $199.9 million (changed N/A YoY), and the FY2025 full-year result was $199.7 million, changed N/A from the prior year.
• Short term Debt was little changed at $199.9 million in Q1 2026, from $199.7 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $199.9 million in Q1 2026 to a low of $120.6 million in Q1 2022.
• A 5-year average of $190.7 million and a median of $199.5 million in 2025 frame the typical range for Short term Debt.